Sander, D;Winbeck, K;Etgen, T;Landgrebe, M;Conrad, B.New aspects of stroke prevention: Modern differential therapy with platelet inhibitors.NERVENHEILKUNDE.2003.22.6.295-+

Ceballos-Baumann, AO.Dementia in Parkinsonism: Clinical and therapeutic aspects.NERVENHEILKUNDE.2003.22.6.287-+

Ceballos-Baumann, A.The role of EMG guidance in botulinum toxin (BTX) therapy.Klinische Neurophysiologie.2003.34.3.138-144

Boecker, H;Haussermann, P;Drzezga, A;Conrad, B;Schwaiger, M;Ceballos-Baumann, A.The metabolic correlate of dementia in Parkinson disease: A fluorine-18-fluorode-oxyglucose (FDG) PET study.J Nucl Med.2003.44 Suppl. .5.237P-237P

Sander, D;Grafman, J;Zalla, T.The human amygdala: an evolved system for relevance detection..Rev Neurosci.2003.14.4.303-16

Sabri, O;Owega, A;Schreckenberger, M;Sturz, L;Fimm, B;Kunert, P;Meyer, PT;Sander, D;Klingelhöfer, J.A truly simultaneous combination of functional transcranial Doppler sonography and H(2)(15)O PET adds fundamental new information on differences in cognitive activation between schizophrenics and healthy control subjects..J Nucl Med.2003.44.5.671-81

Schmidt, B;Czosnyka, M;Raabe, A;Yahya, H;Schwarze, JJ;Sackerer, D;Sander, D;Klingelhöfer, J.Adaptive noninvasive assessment of intracranial pressure and cerebral autoregulation..Stroke.2003.34.1.84-9

Ceballos-Baumann, AO.Functional imaging in Parkinson's disease: activation studies with PET, fMRI and SPECT..J Neurol.2003.250 Suppl.I15-23

Ceballos-Baumann, A.[Diagnosis and treatment of Parkinson's syndrome. What is important for the general practitioner?].MMW Fortschr Med.2003.145 Suppl.99-102

Heckmann, M;Teichmann, B;Schröder, U;Sprengelmeyer, R;Ceballos-Baumann, AO.Pharmacologic denervation of frown muscles enhances baseline expression of happiness and decreases baseline expression of anger, sadness, and fear..J Am Acad Dermatol.2003.49.2.213-6